Cargando…
Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma
BACKGROUND AND PURPOSE: A subgroup of salivary duct carcinoma (SDC) harbor overexpression of the androgen receptor (AR), and co-occurring mutations in the HRAS- and PIK3CA-genes. The impact of genomic complexity on targeted treatment strategies in advanced cancer is unknown. MATERIALS AND METHODS: W...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325704/ https://www.ncbi.nlm.nih.gov/pubmed/37427101 http://dx.doi.org/10.3389/fonc.2023.1107134 |